To access the full text documents, please follow this link:

Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injection.
Romero-Aroca, P.; Sararols, L.; Arias Barquet, Lluís; Casaroli Marano, Ricardo Pedro; Bassaganyas F.
Universitat de Barcelona
Background: The number of patients who have undergone intravitreal injections has increased enormously in recent years, but a consensus is still lacking on prophylaxis for endophthalmitis. The aim of this prospective, observational study was to evaluate the prophylactic effect of azithromycin eye drops versus ofloxacin eye drops. Methods: The study was conducted in five hospitals in Spain and included all patients under going intravitreal injections of triamcinolone, bevacizumab, ranibizumab, or pegaptanib over one year. Patients received azithromycin 15 mg/g eye drops (twice daily on the day prior to injection and for another 2 days) or ofloxacin 3 mg/g eye drops (every 6 hours on the day prior to injection and for another 7 days). Results: In the azithromycin group, there were 4045 injections in 972 eyes of 701 patients. In the ofloxacin group, there were 4151 injections in 944 eyes of 682 patients. There were two cases of endophthalmitis (0.049%) in the azithromycin group and five (0.12%) in the ofloxacin group. The odds ratio of presenting with endophthalmitis in the ofloxacin group compared with the azithromycin group was 2.37 (95% confidence interval [CI] 1.32-3.72, P ,0.001). There were two cases of noninfectious uveitis after triamcinolone injection in the azithromycin group (0.049%) and two (0.048%) in the ofloxacin group; no significant differences were observed (odds ratio 0.902, 95% CI 0.622-1.407, P= 0.407). Conjunctival hyperemia was observed in 12 cases in the azithromycin group and none in the ofloxacin group. Conclusion: The risk of endophthalmitis was significantly greater with ofloxacin than with azithromycin. These findings provide a valuable addition to the ever-increasing pool of infor - mation on endophthalmitis prophylaxis after intravitreal injection, although further large-scale studies are required to provide definitive conclusions.
Infeccions oculars
Cirurgia ocular
Medicina preventiva
Eye infections
Eye surgery
Preventive medicine
cc-by-nc (c) Romero-Aroca, P. et al., 2012
Dove Medical Press

Show full item record

Related documents

Other documents of the same author

Torra i Bou, Joan Enric; Casaroli Marano, Ricardo Pedro; Martínez Cuervo, Fernando; Reina del Pozo, Manuel; Soldevilla Agreda, J.Javier; Vilaró, Senén, 1956-2005
Castellarnau Castella, Conxita; Martín, Mercè; Marcos, Anna; Casaroli Marano, Ricardo Pedro; Reina del Pozo, Manuel; Vilaró, Senén, 1956-2005
Bahadoran, Philippe; Aberdam, Edith; Mantoux, Frédéric; Buscà, Roser; Bille, Karine; Yalman, Nevin; Saint-Basile, Geneviève de; Casaroli Marano, Ricardo Pedro; Ortonne, Jean-Paul; Ballotti, Robert
Casaroli Marano, Ricardo Pedro; Nieto-Nicolau, N.; Martínez-Conesa, E.M.; Edel, Michael John; Álvarez Palomo, Ana Belén
Casaroli Marano, Ricardo Pedro; Reina del Pozo, Manuel; Vilaró, Senén, 1956-2005